• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌黏膜相关菌群特征。

Mucosa-associated microbiota signature in colorectal cancer.

机构信息

Department of GI Surgery, Shanghai Tenth People's Hospital Affiliated to Tongji University School of Medicine, No.301 Yanchang Road, Zhabei District, Shanghai, China.

Research Institute of Intestinal Diseases, Tongji University School of Medicine, Shanghai, China.

出版信息

Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2073-2083. doi: 10.1007/s10096-017-3026-4. Epub 2017 Jun 9.

DOI:10.1007/s10096-017-3026-4
PMID:28600626
Abstract

The aim of this study was to explore the gut microbiota profiles of colorectal cancer (CRC) patients and to examine the relationship between gut microbiota and other key molecular factors involved in CRC tumorigenesis. In this study, a 16S rDNA sequencing platform was used to identify possible differences in the microbiota signature between CRC and adjacent normal mucosal tissue. Differences in the microbiota composition in different anatomical colorectal tumor sites and their potential association with KRAS mutation were also explored. In this study, the number of Firmicutes and Actinobacteria decreased, while the number of Fusobacteria increased in the gut of CRC patients. In addition, at the genus level, Fusobacterium was identified as the key contributor to CRC tumorigenesis. In addition, a different distribution of gut microbiota in ascending and descending colon cancer samples was observed. Lipopolysaccharide biosynthesis-associated microbial genes were enriched in tumor tissues. Our study suggests that specific mucosa-associated microbiota signature and function are significantly changed in the gut of CRC patients, which may provide insight into the progression of CRC. These findings could also be of value in the creation of new prevention and treatment strategies for this type of cancer.

摘要

本研究旨在探讨结直肠癌(CRC)患者的肠道微生物群特征,并研究肠道微生物群与 CRC 肿瘤发生过程中涉及的其他关键分子因素之间的关系。在本研究中,使用 16S rDNA 测序平台来鉴定 CRC 和相邻正常黏膜组织之间微生物群特征的可能差异。还探索了不同解剖学结直肠肿瘤部位的微生物群落组成的差异及其与 KRAS 突变的潜在关联。在本研究中,CRC 患者肠道中的厚壁菌门和放线菌门数量减少,而梭杆菌门数量增加。此外,在属水平上,梭杆菌属被确定为 CRC 肿瘤发生的关键贡献者。此外,还观察到升结肠癌和降结肠癌样本中肠道微生物群的不同分布。与脂多糖生物合成相关的微生物基因在肿瘤组织中富集。我们的研究表明,CRC 患者肠道中特定的黏膜相关微生物群特征和功能发生了显著变化,这可能为 CRC 的进展提供新的见解。这些发现对于开发针对这种癌症的新的预防和治疗策略也可能具有重要价值。

相似文献

1
Mucosa-associated microbiota signature in colorectal cancer.结直肠癌黏膜相关菌群特征。
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2073-2083. doi: 10.1007/s10096-017-3026-4. Epub 2017 Jun 9.
2
Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.1,2-二甲基肼诱导的“腺瘤-癌序列”小鼠结直肠癌模型中肠道微生物群的进化生物学变化
Oncotarget. 2017 Jan 3;8(1):444-457. doi: 10.18632/oncotarget.13443.
3
Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.来自美国和西班牙队列的肿瘤组织与非肿瘤相邻组织之间的肠道微生物群组成和功能差异。
Gut Microbes. 2015;6(3):161-72. doi: 10.1080/19490976.2015.1039223.
4
Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model.鉴定结直肠癌中 KRAS 突变相关的肠道微生物群,并构建预测性机器学习模型。
Microbiol Spectr. 2024 May 2;12(5):e0272023. doi: 10.1128/spectrum.02720-23. Epub 2024 Apr 4.
5
Tumour-associated and non-tumour-associated microbiota in colorectal cancer.结直肠癌中与肿瘤相关和与非肿瘤相关的微生物群
Gut. 2017 Apr;66(4):633-643. doi: 10.1136/gutjnl-2015-309595. Epub 2016 Mar 18.
6
Molecular Analysis of the Microbiome in Colorectal Cancer.结直肠癌中微生物群的分子分析
Methods Mol Biol. 2018;1765:139-153. doi: 10.1007/978-1-4939-7765-9_8.
7
Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.腺瘤性结直肠癌患者与对照受试者的人类肠道微生物群比较:末端限制性片段长度多态性和下一代测序分析。
Oncol Rep. 2016 Jan;35(1):325-33. doi: 10.3892/or.2015.4398. Epub 2015 Nov 4.
8
A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.对结直肠癌的微生物群落组成和基因表达进行全面分析。
BMC Microbiol. 2020 Oct 13;20(1):308. doi: 10.1186/s12866-020-01938-w.
9
Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.结直肠肿瘤发生过程中肠道微生物群和血浆炎症因子的变化:一项病例对照研究。
BMC Microbiol. 2018 Aug 29;18(1):92. doi: 10.1186/s12866-018-1232-6.
10
Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis.结直肠肿瘤内微生物群落的异质性及其与结直肠癌发生的关系。
Gastroenterology. 2021 Jun;160(7):2395-2408. doi: 10.1053/j.gastro.2021.02.020. Epub 2021 Feb 11.

引用本文的文献

1
Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials.基于纳米材料的癌症治疗中靶向肿瘤微生物群
Exploration (Beijing). 2025 Mar 24;5(4):e20210185. doi: 10.1002/EXP.20210185. eCollection 2025 Aug.
2
On exploring cross-sectional stability and persistence of microbiome in a multiple body site colorectal cancer dataset.探索多身体部位结直肠癌数据集中微生物组的横断面稳定性和持久性。
Front Microbiol. 2025 May 30;16:1449642. doi: 10.3389/fmicb.2025.1449642. eCollection 2025.
3
The power of microbes: the key role of gut microbiota in the initiation and progression of colorectal cancer.

本文引用的文献

1
Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes.右半结肠癌与左半结肠癌生物学特性:整合共识分子亚型。
J Natl Compr Canc Netw. 2017 Mar;15(3):411-419. doi: 10.6004/jnccn.2017.0038.
2
Impact of Primary Tumor Location on Postoperative Recurrence and Subsequent Prognosis in Nonmetastatic Colon Cancers: A Multicenter Retrospective Study Using a Propensity Score Analysis.原发肿瘤部位对非转移性结肠癌术后复发及预后的影响:一项基于倾向评分分析的多中心回顾性研究。
Ann Surg. 2018 May;267(5):917-921. doi: 10.1097/SLA.0000000000002206.
3
Race-dependent association of sulfidogenic bacteria with colorectal cancer.
微生物的力量:肠道微生物群在结直肠癌发生和发展中的关键作用。
Front Oncol. 2025 Apr 14;15:1563886. doi: 10.3389/fonc.2025.1563886. eCollection 2025.
4
Intestinal crypt microbiota modulates intestinal stem cell turnover and tumorigenesis via indole acetic acid.肠道隐窝微生物群通过吲哚乙酸调节肠道干细胞更替和肿瘤发生。
Nat Microbiol. 2025 Mar;10(3):765-783. doi: 10.1038/s41564-025-01937-5. Epub 2025 Feb 19.
5
The mycobiome as integral part of the gut microbiome: crucial role of symbiotic fungi in health and disease.真菌微生物群作为肠道微生物群的组成部分:共生真菌在健康与疾病中的关键作用。
Gut Microbes. 2024 Jan-Dec;16(1):2440111. doi: 10.1080/19490976.2024.2440111. Epub 2024 Dec 15.
6
Gut microbiota and metabolites associated with immunotherapy efficacy in extensive-stage small cell lung cancer: a pilot study.广泛期小细胞肺癌中与免疫治疗疗效相关的肠道微生物群和代谢产物:一项初步研究。
J Thorac Dis. 2024 Oct 31;16(10):6936-6954. doi: 10.21037/jtd-24-1201. Epub 2024 Oct 14.
7
Evaluation of Periodontitis and Among Colorectal Cancer Patients: An Observational Cross-Sectional Study.结直肠癌患者牙周炎及[具体内容缺失]的评估:一项观察性横断面研究。
Healthcare (Basel). 2024 Nov 4;12(21):2189. doi: 10.3390/healthcare12212189.
8
Biological and Clinical Characteristics of Proximal Colon Cancer: Far from Its Anatomical Subsite.近端结肠癌的生物学和临床特征:与其解剖亚部位相去甚远。
Int J Med Sci. 2024 Jul 9;21(10):1824-1839. doi: 10.7150/ijms.97574. eCollection 2024.
9
Microbiome Dysbiosis, Dietary Intake and Lifestyle-Associated Factors Involve in Epigenetic Modulations in Colorectal Cancer: A Narrative Review.肠道微生物失调、饮食摄入和生活方式相关因素参与结直肠癌的表观遗传调控:叙事性综述。
Cancer Control. 2024 Jan-Dec;31:10732748241263650. doi: 10.1177/10732748241263650.
10
Rapid detection of FadA in Fusobacterium nucleatum using the quantitative LAMP colorimetric phenol red method in stool samples from colorectal cancer patients.利用定量环介导等温扩增(LAMP)比色法检测粪便样本中具核梭杆菌 FadA 快速诊断结直肠癌。
Sci Rep. 2024 Jun 14;14(1):13739. doi: 10.1038/s41598-024-62846-x.
产硫化物细菌与结直肠癌的种族依赖性关联。
Gut. 2017 Nov;66(11):1983-1994. doi: 10.1136/gutjnl-2016-313321. Epub 2017 Feb 2.
4
Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice.厌氧消化链球菌通过诱导结肠细胞内胆固醇生物合成来促进增殖,并在小鼠中引起发育异常。
Gastroenterology. 2017 May;152(6):1419-1433.e5. doi: 10.1053/j.gastro.2017.01.009. Epub 2017 Jan 23.
5
Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle.肠道微生物组研究进展:开启应对西方生活方式的新策略
Front Genet. 2017 Jan 10;7:224. doi: 10.3389/fgene.2016.00224. eCollection 2016.
6
The Human Microbiome and Cancer.人类微生物组与癌症
Cancer Prev Res (Phila). 2017 Apr;10(4):226-234. doi: 10.1158/1940-6207.CAPR-16-0249. Epub 2017 Jan 17.
7
Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle.微生物群失调:解开癌症发生之谜的新线索。
J Med Microbiol. 2016 Dec;65(12):1347-1362. doi: 10.1099/jmm.0.000371. Epub 2016 Oct 21.
8
Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.具核梭杆菌通过激活Toll样受体4信号传导至核因子κB并上调微小RNA-21的表达来增加结肠直肠癌细胞的增殖和小鼠肿瘤的发展。
Gastroenterology. 2017 Mar;152(4):851-866.e24. doi: 10.1053/j.gastro.2016.11.018. Epub 2016 Nov 19.
9
Diet, microorganisms and their metabolites, and colon cancer.饮食、微生物及其代谢产物与结肠癌
Nat Rev Gastroenterol Hepatol. 2016 Dec;13(12):691-706. doi: 10.1038/nrgastro.2016.165. Epub 2016 Nov 16.
10
Microbiome-driven carcinogenesis in colorectal cancer: Models and mechanisms.微生物群驱动的结直肠癌致癌作用:模型与机制
Free Radic Biol Med. 2017 Apr;105:3-15. doi: 10.1016/j.freeradbiomed.2016.10.504. Epub 2016 Oct 31.